Cargando…
Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)
BACKGROUND: Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The objective of the study was to describe the prevalence and...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774144/ https://www.ncbi.nlm.nih.gov/pubmed/29347939 http://dx.doi.org/10.1186/s12931-018-0719-x |
_version_ | 1783293711537405952 |
---|---|
author | Larsson, Kjell Ställberg, Björn Lisspers, Karin Telg, Gunilla Johansson, Gunnar Thuresson, Marcus Janson, Christer |
author_facet | Larsson, Kjell Ställberg, Björn Lisspers, Karin Telg, Gunilla Johansson, Gunnar Thuresson, Marcus Janson, Christer |
author_sort | Larsson, Kjell |
collection | PubMed |
description | BACKGROUND: Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The objective of the study was to describe the prevalence and managemant of severe asthma in a Swedish asthma popuöation. METHODS: In this observational cohort study, primary care medical records data (2006–2013) from 36 primary health care centers were linked to data from national mandatory Swedish health registries. The studied population (>18 years) had a record of drug collection for obstructive pulmonary disease (ATC code R03) during 2011–2012, and a physician diagnosed asthma (ICD-10 code J45-J46) prior to drug collection. Severe asthma was classified as collection of high dose inhaled steroid (> 800 budesonide or equivalent per day) and leukotriene receptor antagonist and/or long-acting beta-agonist. Poor asthma control was defined as either collection of ≥600 doses of short-acting beta-agonists, and/or ≥1 exacerbation(s) during the year post index date. RESULTS: A total of 18,724 asthma patients (mean 49 years, 62.8% women) were included, of whom 17,934 (95.8%) had mild to moderate and 790 (4.2%) had severe asthma. Exacerbations were more prevalent in severe asthma (2.59 [2.41–2.79], Relative Risk [95% confidence interval]; p < 0.001). Poor asthma control was observed for 28.2% of the patients with mild to moderate asthma and for more than half (53.6%) of the patients with severe asthma (<0.001). Prior to index, one in five severe asthma patients had had a contact with secondary care and one third with primary care. A concurrent COPD diagnosis increased disease burden. CONCLUSION: Severe asthma was found in 4.2% of asthma patients in Sweden, more than half of them had poor asthma control, and most patients had no regular health care contacts. |
format | Online Article Text |
id | pubmed-5774144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57741442018-01-26 Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) Larsson, Kjell Ställberg, Björn Lisspers, Karin Telg, Gunilla Johansson, Gunnar Thuresson, Marcus Janson, Christer Respir Res Research BACKGROUND: Severe and uncontrolled asthma is associated with increased risk of exacerbations and death. A substantial proportion of asthma patients have poor asthma control, and a concurrent COPD diagnosis often increases disease burden. The objective of the study was to describe the prevalence and managemant of severe asthma in a Swedish asthma popuöation. METHODS: In this observational cohort study, primary care medical records data (2006–2013) from 36 primary health care centers were linked to data from national mandatory Swedish health registries. The studied population (>18 years) had a record of drug collection for obstructive pulmonary disease (ATC code R03) during 2011–2012, and a physician diagnosed asthma (ICD-10 code J45-J46) prior to drug collection. Severe asthma was classified as collection of high dose inhaled steroid (> 800 budesonide or equivalent per day) and leukotriene receptor antagonist and/or long-acting beta-agonist. Poor asthma control was defined as either collection of ≥600 doses of short-acting beta-agonists, and/or ≥1 exacerbation(s) during the year post index date. RESULTS: A total of 18,724 asthma patients (mean 49 years, 62.8% women) were included, of whom 17,934 (95.8%) had mild to moderate and 790 (4.2%) had severe asthma. Exacerbations were more prevalent in severe asthma (2.59 [2.41–2.79], Relative Risk [95% confidence interval]; p < 0.001). Poor asthma control was observed for 28.2% of the patients with mild to moderate asthma and for more than half (53.6%) of the patients with severe asthma (<0.001). Prior to index, one in five severe asthma patients had had a contact with secondary care and one third with primary care. A concurrent COPD diagnosis increased disease burden. CONCLUSION: Severe asthma was found in 4.2% of asthma patients in Sweden, more than half of them had poor asthma control, and most patients had no regular health care contacts. BioMed Central 2018-01-18 2018 /pmc/articles/PMC5774144/ /pubmed/29347939 http://dx.doi.org/10.1186/s12931-018-0719-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Larsson, Kjell Ställberg, Björn Lisspers, Karin Telg, Gunilla Johansson, Gunnar Thuresson, Marcus Janson, Christer Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) |
title | Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) |
title_full | Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) |
title_fullStr | Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) |
title_full_unstemmed | Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) |
title_short | Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR) |
title_sort | prevalence and management of severe asthma in primary care: an observational cohort study in sweden (pacehr) |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774144/ https://www.ncbi.nlm.nih.gov/pubmed/29347939 http://dx.doi.org/10.1186/s12931-018-0719-x |
work_keys_str_mv | AT larssonkjell prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr AT stallbergbjorn prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr AT lissperskarin prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr AT telggunilla prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr AT johanssongunnar prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr AT thuressonmarcus prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr AT jansonchrister prevalenceandmanagementofsevereasthmainprimarycareanobservationalcohortstudyinswedenpacehr |